MONTCLAIR, N.J., June 15, 2017 – Dr. Vincent Giampapa’s Global Foundation for Human Aging Research has donated $50,000 to the Harvard Medical School geneticist and aging researcher David Sinclair to support his work toward unraveling the mysteries of aging.
“The mission of the Sinclair Lab is exactly in line with the mission of our foundation,” says Dr. Vincent Giampapa, founder of the Global Foundation for Human Aging Research, “and that’s why we’ve donated $50,000 to its ongoing efforts.”
Scientists at the Sinclair Lab study the processes that fuel aging and age-related diseases and work toward discovering methods for slowing down or reversing these processes. The work ranges from dissecting novel pathways and identifying target genes, to assessing small molecules that may slow the pace of aging and increase health span.
Earlier this year, Dr. Giampapa met Sinclair and was intrigued by Sinclair’s work with NMN — a molecule that appears to protect against DNA degradation and slow down aging in mice. Human trials are expected to begin later this year, according to the Harvard Gazette.
“I believe the faculty at the Sinclair Lab is doing first-rate work that will have major global impact, and that’s why the foundation is supporting their mission,” says Dr. Giampapa. “Shifting our health care system into a ‘prevention and wellness’ mode will require new technologies and treatments, and those treatments must go beyond symptom suppression. Dr. Sinclair’s work with NMN is an example of this forward-thinking approach.”
The major challenges facing health care systems in the future will be demographic in nature, which underscores the need for a paradigm shift on how medical professionals think about aging. According to the Pew Research Center, global population growth will slow significantly between now and 2050. Consequently, the share of people over age 65 will increase. Some regions will feel this more than others; East Asia, for instance, is already facing stiff challenges in how to care for its aging populations. For his part, Dr. Giampapa sees the Sinclair Lab’s work as part of the solution to this slow-motion crisis.
Using Dr. Sinclair’s “ICE Mice Model,” which measures a compound’s anti-aging effects at the genetic level, Dr. Giampapa believes companies have a promising, accelerated way of testing natural compounds’ potency and efficacy without having to wait a lifetime for human tests. Many natural compounds may have significant effects on slowing human aging, which makes this accelerated testing methodology critical.
“I look forward to witnessing new technologies help the world’s aging population experience a better quality of life, lower health care costs, and reduced dependence on prescription drugs,” concludes Dr. Giampapa.
About the Global Foundation for Human Aging Research
The Global Foundation for Human Aging Research is a nonprofit organization working to support the front lines of medical research and development related to the biology of human aging with the goal of improving health span for aging populations worldwide. It contributes funds to other non-profit institutions, universities, and companies that are working in line with its mission. It was founded by renowned anti-aging medicine pioneer Dr. Vincent Giampapa, M.D., F.A.C.S.
SOURCE Global Foundation for Human Aging Research